Abstract
Introduction: The link between nasal obstruction and muscle tension dysphonia (MTD) has not been previously investigated despite the well-established relationship between respiratory and voice disorders. The aim of this study was to examine the prevalence of nasal obstruction and sinonasal symptoms in patients with primary MTD. Methods: Patients presenting to the Voice Unit at a tertiary referral center between July 2022 and October 2023 and diagnosed with primary MTD were recruited. The severity of nasal obstruction was assessed using the Visual Analogue Scale (VAS), and sinonasal symptoms were assessed using the Sinonasal Outcome Test-22 (SNOT-22) questionnaire. A control group matched by age and gender, with no dysphonia and normal laryngeal examination was recruited. Results: 65 patients, 31 with MTD and 34 controls, were enrolled. Nineteen patients of the study group (61.3%) had a VAS >4, i.e., moderate to severe nasal obstruction compared to only five in the control group (14.7%) (p < 0.001). Using the SNOT-22, 61.3% of patients with MTD had moderate to severe sinonasal symptoms as compared to only 5.9% of the control group (p < 0.001). Conclusions: Patients with primary MTD are more likely to have nasal obstruction/sinonasal symptoms in comparison to patients with no dysphonia and normal laryngeal examination.
Journal Section:
Research Article
References
1.
Andrea
M
, Andrea
M
, Figueira
ML
. Self-perception of quality of life in patients with functional voice disorders: the effects of psychological and vocal acoustic variables
. Eur Arch Otorhinolaryngol
. 2018
;275
(11
):2745
–54
. 2.
Dromey
C
, Nissen
SL
, Roy
N
, Merrill
RM
. Articulatory changes following treatment of muscle tension dysphonia: preliminary acoustic evidence
. J Speech Lang Hear Res
. 2008
;51
(1
):196
–208
. 3.
Gregory
ND
, Chandran
S
, Lurie
D
, Sataloff
RT
. Voice disorders in the elderly
. J Voice
. 2012
;26
(2
):254
–8
. 4.
Garaycochea
O
, Navarrete
JMA
, Del Río
B
, Fernández
S
. Muscle tension dysphonia: which laryngoscopic features can we rely on for diagnosis
. J Voice
. 2019
;33
(5
):812.e15
–812.e18
. 5.
Thomas
CM
, Rhodes
D
, Mehta
M
, Alexander
J
. Methods of measuring laryngeal muscle tension in patients with muscle tension dysphonia: a scoping review
. J Voice
. 2023
. Published online April 15.6.
McGarey
POJ
, Barone
NA
, Freeman
M
, Daniero
JJ
. Comorbid dysphagia and dyspnea in muscle tension dysphonia: a global laryngeal musculoskeletal problem
. OTO Open
. 2018
;2
(3
):2473974X18795671
. 7.
Hamdan
AL
, Ghanem
A
, Hosri
J
, Abou Raji Feghali
P
, Abi Zeid Daou
C
, Fadel
C
, et al. Prevalence of laryngeal muscle tension in patients with obstructive sleep apnea
. J Voice
. 2023
. Published online July 9, 2023.8.
Ahmadi
N
, Moein
N
, Tarameshlu
M
, Ghelichi
L
, Kamali
M
, Jenabi
MS
. The effect of breathing exercises combined with manual therapy on muscle tension dysphonia in traditional singers: a blinded randomized controlled trial
. Eur Arch Otorhinolaryngol
. 2022
;279
(6
):2989
–96
. 9.
Lim
M
, Lew-Gor
S
, Darby
Y
, Brookes
N
, Scadding
G
, Lund
VJ
. The relationship between subjective assessment instruments in chronic rhinosinusitis
. Rhinology
. 2007
;45
(2
):144
–7
.10.
Toma
S
, Hopkins
C
. Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments
. Rhinology
. 2016
;54
(2
):129
–33
. 11.
Belafsky
PC
, Postma
GN
, Koufman
JA
. Validity and reliability of the reflux symptom index (RSI)
. J Voice
. 2002
;16
(2
):274
–7
. 12.
Lowell
SY
, Colton
RH
, Kelley
RT
, Auld
M
, Schmitz
H
. Isolated and combined respiratory training for muscle tension dysphonia: preliminary findings
. J Voice
. 2022
;36
(3
):361
–82
. 13.
Lowell
SY
, Barkmeier-Kraemer
JM
, Hoit
JD
, Story
BH
. Respiratory and laryngeal function during spontaneous speaking in teachers with voice disorders
. J Speech Lang Hear Res
. 2008
;51
(2
):333
–49
. 14.
Hiyama
S
, Ono
T
, Ishiwata
Y
, Kuroda
T
, Ohyama
K
. Effects of experimental nasal obstruction on human masseter and suprahyoid muscle activities during sleep
. Angle Orthod
. 2003
;73
(2
):151
–7
. 15.
Trevisan
ME
, Boufleur
J
, Soares
JC
, Haygert
CJP
, Ries
LGK
, Corrêa
ECR
. Diaphragmatic amplitude and accessory inspiratory muscle activity in nasal and mouth-breathing adults: a cross-sectional study
. J Electromyogr Kinesiol
. 2015
;25
(3
):463
–8
. 16.
Ribeiro
EC
, Marchiori
SC
, da Silva
AM
. Electromyographic muscle EMG activity in mouth and nasal breathing children
. Cranio
. 2004
;22
(2
):145
–50
. 17.
Kunduk
M
, Fink
DS
, McWhorter
AJ
. Primary muscle tension dysphonia
. Curr Otorhinolaryngol Rep
. 2016
;4
(3
):175
–82
. 18.
Martinez
CC
, Lemos
IO
, Madazio
G
, Behlau
M
, Cassol
M
. Vocal parameters, muscle palpation, self-perception of voice symptoms, pain, and vocal fatigue in women with muscle tension dysphonia
. Codas
. 2021
;33
(4
):e20200035
. 19.
Jaruvongvanich
V
, Mongkolpathumrat
P
, Chantaphakul
H
, Klaewsongkram
J
. Extranasal symptoms of allergic rhinitis are difficult to treat and affect quality of life
. Allergol Int
. 2016
;65
(2
):199
–203
. 20.
Vertigan
AE
, Kapela
SM
, Kearney
EK
, Gibson
PG
. Laryngeal dysfunction in cough hypersensitivity syndrome: a cross-sectional observational study
. J Allergy Clin Immunol Pract
. 2018
;6
:2087
–95
. 21.
Koufman
JA
, Amin
MR
, Panetti
M
. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders
. Otolaryngol Head Neck Surg
. 2000
;123
(4
):385
–8
. 22.
Lou
Z
, Lou
ZH
. Laryngopharyngeal reflux is a potential cause of nasal congestion and obstructive sleep apnea syndrome
. Eur Arch Otorhinolaryngol
. 2018
;275
(9
):2409
–11
. 23.
Hamizan
AW
, Choo
YY
, Loh
PV
, Abd Talib
NF
, Mohd Ramli
MF
, Zahedi
FD
, et al. The association between the reflux symptoms index and nasal symptoms among patients with non-allergic rhinitis
. J Laryngol Otol
. 2021
;135
(2
):142
–6
. 24.
Titze
IR
. Acoustic interpretation of resonant voice
. J Voice
. 2001
;15
(4
):519
–28
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
